Error loading player: No playable sources found
64243
Technical Seminar presented by Cygnus Technologies
Date
June 28, 2023
This product is not available for individual purchase, but it is available as part of the following products:
The Cell and Gene Therapy Products (CGTP) Symposium: Manufacturing, Quality and Regulatory Considerations enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products…
Analytics for Process-related Impurities in Viral Vector Manufacturing
Alla Zilberman, Cygnus Technologies, Inc.
Alla Zilberman, Cygnus Technologies, Inc.
Speaker
General
Tracks
Related Products
Parallel Session 10: Platform Development Approaches for AAV Gene Therapy Products
With the recent approval of several Adeno-Associated Virus (AAV)-based gene therapies, the application of AAV gene therapy approaches to the treatment of human disease is expanding…
Plenary Session 5: Challenges with Incoming Materials - Raw, Starting, Ancillary, etc.
Raw material selection decisions early in the development of ATMPs are crucial and can impact the final product quality and ultimately patient safety…
Parallel Session 1: CMC Challenges with Ultra Rare Diseases
Bringing treatment to those afflicted with an ultra-rare disease is complex. These products are encumbered with challenges ranging from high development costs with a limited ROI, to issues with executing and interpreting clinical trials with unusually small patient populations…
Technical Seminar presented by MilliporeSigma
Ensuring the Virus Safety Profile of Your Product - Expectations and Recommendations From the Latest Update to ICH Q5A
